🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

3,061 results for “Bio” Clear

  1. CEA CAR-T cells

    Chongqing Precision Biotech Co., Ltd

    Colorectal Cancer

    phase 1 mab active

    1 trial

  2. CEA CAR-T cells

    Chongqing Precision Biotech Co., Ltd

    Gastric Cancer

    phase 1 mab active

    1 trial

  3. CEA-targeted CAR-T (Intravenous)

    Chongqing Precision Biotech Co., Ltd

    NSCLC (Advanced Non-small Cell Lung Cancer)

    phase 1 mab active

    1 trial

  4. CEA-targeted CAR-T cells

    Chongqing Precision Biotech Co., Ltd

    Lung Cancer

    phase 1 mab active

    1 trial

  5. CEA-targeted CAR-T cells

    Chongqing Precision Biotech Co., Ltd

    Peritoneal Metastases From Colorectal Cancer

    phase 1 mab active

    1 trial

  6. CEA-targeted CAR-T cells

    Chongqing Precision Biotech Co., Ltd

    Colorectal Cancer

    phase 1 mab active

    1 trial

  7. CG-806

    Aptose Biosciences

    Acute Myeloid Leukemia

    phase 1 small molecule terminated

    1 trial

  8. CG-806

    Aptose Biosciences

    Chronic Lymphocytic Leukemia

    phase 1 small molecule terminated

    1 trial

  9. CGT4255

    Cogent Biosciences

    Advanced Solid Tumor, Adult

    phase 1 small molecule active

    1 trial

  10. CGT6297

    Cogent Biosciences

    PIK3CA Mutations

    phase 1 small molecule active

    1 trial

  11. CHS-1701

    Coherus Oncology

    Bioequivalence

    phase 1 small molecule completed

    1 trial

  12. CI-581a

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Dependence

    phase 1 small molecule completed

    1 trial

  13. CLR 131

    Cellectar Biosciences

    Pediatric Solid Tumor

    phase 1 small molecule active

    1 trial

  14. CLR 131

    Cellectar Biosciences

    High-Grade Glioma

    phase 1 small molecule active

    1 trial

  15. CLR 131

    Cellectar Biosciences

    Head and Neck Cancer

    phase 1 small molecule completed

    1 trial

  16. COVID-19 Therapeutic Biologic Mix - NOVAVAX COVID-19 VACCINE plus BCG Vaccine Mix for percutaneous use

    Lxo Ireland Designated Activity Company

    Covid19

    phase 1 mab active

    1 trial

  17. CS-1103

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorders

    phase 1 small molecule completed

    1 trial

  18. CUE-101

    Cue Biopharma

    Head and Neck Cancer

    phase 1 small molecule completed

    1 trial

  19. CUE-102

    Cue Biopharma

    Colorectal Cancer

    phase 1 small molecule completed

    1 trial

  20. CUE-102

    Cue Biopharma

    Recurrent Glioblastoma

    phase 1 mab active

    1 trial

  21. CVL-354

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 1 small molecule completed

    1 trial

  22. CVL-354

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  23. Cannabidiol, Medium Dose

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis

    phase 1 small molecule active

    1 trial

  24. Cannabis

    BRIGHT MINDS BIOSCIENCES INC.

    Pain

    phase 1 small molecule active

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources